𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The case for early endocrine treatment of advanced or metastatic prostate cancer

✍ Scribed by Schmidt, Joseph D.

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
382 KB
Volume
28
Category
Article
ISSN
0270-4137

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Detection of circulating tumor cells in
Detection of circulating tumor cells in the peripheral blood of patients with androgen-independent, advanced or metastatic prostate cancer
✍ Michael C. Mitas; Uzair B. Chaudhary; David T. Marshall; Sebastiano Gattoni-Cell πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 121 KB πŸ‘ 2 views

## Detection of circulating tumor cells in the peripheral blood of patients with androgen-independent, advanced or metastatic prostate cancer To the Editor: The presence of circulating tumor cells (CTC) in the peripheral blood of cancer patients has attracted a great deal of attention among invest

Time for revival of estrogens in the tre
Time for revival of estrogens in the treatment of advanced prostatic carcinoma? Pharmacokinetics, and endocrine and clinical effects, of a parenteral estrogen regimen
✍ Henriksson, Peter; CarlstrοΏ½m, Kjell; Pousette, οΏ½ke; Gunnarsson, P.O.; Johansson, πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 235 KB πŸ‘ 1 views

## BACKGROUND. The present pilot study tested the clinical performance of a new pharmacokinetically guided dosing regimen of parenteral estrogen in patients with advanced prostatic carcinoma. The aim was to accelerate endocrine effects and to avoid cardiovascular side effects. METHODS. Seventeen p

Brachytherapy and continuous infusion 5-
Brachytherapy and continuous infusion 5-fluorouracil for the treatment of locally advanced, lymph node negative, prostate cancer: A phase I trial
✍ William A. See; Robert Dreicer; James A. Wheeler; Paula K. Forest; Stefan Loenin πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 405 KB πŸ‘ 1 views

BACKGROUND. 5-fluorouracil (5-FU) is a known radiosensitizer that enhances efficacy, in vivo and in vitro, when administered during radiotherapy. The following study was performed to evaluate the toxicity of continuous infusion 5-FU administered concomitant with brachytherapy in patients with locall